StockNews.AI
THTX
StockNews.AI
82 days

Theratechnologies Reports on its Annual Meeting of Shareholders

1. Theratechnologies held its annual meeting virtually on May 29, 2025. 2. Shareholders elected new board members and appointed KPMG as auditors. 3. An omnibus long-term incentive plan was approved for directors and executives. 4. Election results showed various levels of support for new board members. 5. The company focuses on innovative therapies to redefine care standards.

4m saved
Insight
Article

FAQ

Why Neutral?

The meeting's outcomes are standard corporate governance practices with no major announcements. Historically, similar events have led to minimal immediate price impact.

How important is it?

While the event is important for corporate structure, it lacks disclosures on strategic initiatives or financial forecasts.

Why Short Term?

Any immediate impacts from governance changes and new board members will likely stabilize quickly. Long-term effects depend on strategic decisions made by the new board.

Related Companies

KPMGTHNASDAQ
May 29, 2025 14:00 ET  | Source: Theratechnologies MONTREAL, May 29, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, reported the voting results from its annual meeting of shareholders held today in a virtual-only setting. Shareholders proceeded to elect the below candidates to the Company’s Board of Directors for a one-year term, appointed KPMG LLP as the Company’s auditors for the current fiscal year and approved the adoption of an omnibus long-term incentive plan for the benefits of the directors, executive officers and employees of the Company and those of its subsidiaries. All candidates proposed for the position of director were elected in the following proportion:  FOR% FORABSTENTION% ABSTENTIONJoseph Arena20,473,94484.03%3,890,22215.97%Frank Holler19,089,78678.35%5,274,38021.65%Paul Lévesque19,027,77278.10%5,336,39421.90%Andrew Molson19,066,14578.25%5,298,02121.75%Dawn Svoronos18,998,23077.98%5,365,93622.02%Elina Tea19,163,50278.65%5,200,66421.35%Dale Weil19,005,76878.01%5,358,39821.99%Jordan Zwick19,618,72580.52%4,745,44119.48%      About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter). Contacts: Investor inquiries:Philippe DubucSenior Vice President and Chief Financial Officerpdubuc@theratech.com438-315-6608 Media inquiries:Julie SchneidermanSenior Director, Communications & Corporate Affairscommunications@theratech.com514-336-7800

Related News